Listen: Vertex’s regime change, the return of Ebola, & the rise of digital health
What makes an epidemic newsworthy? Can biotech succession succeed? And what’s so novel about digital health?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, our colleague Matthew Herper joins us to talk about the executive shakeup at Vertex Pharmaceuticals, a company that went from the brink of extinction to biotech dominance. Then, we’ll talk about the dawn of the digital health IPO and what it means for a nascent space. Finally, STAT’s Helen Branswell stops by to explain why the latest Ebola virus outbreak hasn’t made nearly as many headlines as the last one.
